mdDear Prospective Client:

Thank you for showing interest in purchasing shares of Intravenous Infusions Limited (IIL), the single largest producer and supplier of intravenous fluids (IV fluids) to hospitals and pharmacies across Ghana.

We consider IIL to be one of Ghana’s good-news stories. Launched in 1974, IIL is the oldest and most reliable indigenous IV fluids producer in Ghana and West Africa. We currently supply between 50-60% of the IV fluids going to hospitals and pharmacies nationwide, and export approximately 10% of our products to neighboring countries such as Cote d’Ivoire, Burkina Faso and Togo. IV fluids are considered live-saving drugs and, as such fall into a niche area of the pharmaceutical industry. That means that our success, and your success as a shareholder, does not depend on how the economy is performing, how much you or I earn or what the latest trend is. IV fluids save lives and that’s what we’re here to do.

As a firm, we are excited about the journey we are embarking on with the launch of our IPO, and we want you to become a part of the IIL family. I encourage you to read the prospectus in detail so that you can learn more about our company, our industry and the exciting future of Intravenous Infusions. We also explain to you how we intend on growing the revenue of the company using the capital raised through the IPO, how we are well-positioned to drive our export business and why you don’t have to miss out on the opportunity of having a stake in a well-run Ghanaian company. Above all, you will read how, with your help, we will be able to save more lives.

Once again, we are grateful for your show of interest, and we hope you will partner with us on this journey.

Best regards,


Mr. Richard Okrah

Managing Director, Intravenous Infusions Limited